Atea Pharmaceuticals, Inc.
AVIR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001593899
No open-market purchases or sales by Atea Pharmaceuticals, Inc. insiders were filed in the last 90 days; 124 institutions reported holding it in 13F filings for Q2 2026, worth $276.4M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Atea Pharmaceuticals, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 111
- −1 vs. Q3 2025
- Shares held
- 57.0M
- +3.94M (+7.4%) vs. Q3 2025
- Total value
- $203.5M
- +$49.6M (+32.2%) vs. Q3 2025
- New holders
- 11
- 30 more added
- Sold out
- 12
- 43 more reduced
3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVIR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 124 | $276.4M |
| Q1 2026 | 127 | $322.8M |
| Q4 2025 | 111 | $203.5M |
| Q3 2025 | 115 | $154.2M |
| Q2 2025 | 107 | $189.7M |
| Q1 2025 | 104 | $158.3M |
| Q4 2024 | 107 | $188.7M |
| Q3 2024 | 108 | $194.0M |
| Q2 2024 | 105 | $187.7M |
| Q1 2024 | 113 | $219.6M |
| Q4 2023 | 108 | $168.3M |
| Q3 2023 | 119 | $170.6M |
| Q2 2023 | 133 | $213.3M |
| Q1 2023 | 131 | $190.2M |
| Q4 2022 | 131 | $278.1M |
| Q3 2022 | 126 | $326.8M |
| Q2 2022 | 128 | $408.7M |
| Q1 2022 | 127 | $396.6M |
| Q4 2021 | 143 | $479.2M |
| Q3 2021 | 142 | $1.99B |
| Q2 2021 | 104 | $1.27B |
| Q1 2021 | 82 | $3.20B |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Atea Pharmaceuticals, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rockefeller Capital Management L.P. | 940 | $3.36K | 0.00% | +940 | New |
| CWM, LLC | 422 | $2.00K | 0.00% | −209−33.1% | Reduced |
| Daiwa Securities Group Inc. | 242 | $1.00K | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 207 | $739 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 149 | $532 | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 106 | $378 | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 95 | $340 | 0.00% | 00.0% | Unchanged |
| Rothschild Investment LLC | 85 | $303 | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 8 | $29 | 0.00% | −191−96.0% | Reduced |
| IFP Advisors, Inc | 4 | $14 | 0.00% | +1+33.3% | Added |
| SBI Securities Co., Ltd. | 2 | $7 | 0.00% | −2−50.0% | Reduced |
| Newtyn Management, LLC | 0 | $0 | 0.00% | −492,284−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −70,000−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −29,450−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −28,199−100.0% | Sold out |
| Bluefin Capital Management, LLC | 0 | $0 | 0.00% | −24,216−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −22,618−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −16,100−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −14,466−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −10,135−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −63−100.0% | Sold out |
| Covestor Ltd | 0 | $0 | 0.00% | −93−100.0% | Sold out |
| Cloud Capital Management, LLC | 0 | $0 | 0.00% | −59−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | – | – | – | – | Not filed |
| Wolverine Trading, LLC | – | – | – | – | Not filed |
| Point72 Asia (Singapore) Pte. Ltd. | – | – | – | – | Not filed |